GB0900599D0 - Treatment - Google Patents

Treatment

Info

Publication number
GB0900599D0
GB0900599D0 GB0900599A GB0900599A GB0900599D0 GB 0900599 D0 GB0900599 D0 GB 0900599D0 GB 0900599 A GB0900599 A GB 0900599A GB 0900599 A GB0900599 A GB 0900599A GB 0900599 D0 GB0900599 D0 GB 0900599D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0900599A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novacta Biosystems Ltd
Original Assignee
Novacta Biosystems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novacta Biosystems Ltd filed Critical Novacta Biosystems Ltd
Priority to GB0900599A priority Critical patent/GB0900599D0/en
Publication of GB0900599D0 publication Critical patent/GB0900599D0/en
Priority to PCT/GB2010/000043 priority patent/WO2010082019A1/en
Ceased legal-status Critical Current

Links

GB0900599A 2009-01-14 2009-01-14 Treatment Ceased GB0900599D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0900599A GB0900599D0 (en) 2009-01-14 2009-01-14 Treatment
PCT/GB2010/000043 WO2010082019A1 (en) 2009-01-14 2010-01-12 Actagardine derivatives, and pharmaceutical use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0900599A GB0900599D0 (en) 2009-01-14 2009-01-14 Treatment

Publications (1)

Publication Number Publication Date
GB0900599D0 true GB0900599D0 (en) 2009-02-18

Family

ID=40409976

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0900599A Ceased GB0900599D0 (en) 2009-01-14 2009-01-14 Treatment

Country Status (2)

Country Link
GB (1) GB0900599D0 (en)
WO (1) WO2010082019A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
EP2387580B1 (en) 2009-01-14 2014-08-13 Novacta Biosystems Limited Deoxyactagardine derivatives
JP5731407B2 (en) 2009-02-04 2015-06-10 ノヴァクタ バイオシステムズ リミティッド Actagardine derivatives
GB201001688D0 (en) * 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8507528D0 (en) 1985-03-22 1985-05-01 Lepetit Spa Basis monocarboxyamide derivatives
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (en) 1990-01-23 1999-01-15 . Cyclodextrin derivatives with increased water solubility and uses thereof
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
DE19745583A1 (en) * 1997-10-15 1999-04-22 Hoechst Marion Roussel De Gmbh New actagardine derivatives with extra N-terminal amino acid
PL202623B1 (en) 2000-06-28 2009-07-31 Smithkline Beecham Plc Wet milling process
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714029D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity

Also Published As

Publication number Publication date
WO2010082019A1 (en) 2010-07-22

Similar Documents

Publication Publication Date Title
GB0823213D0 (en) Treatment
PL2652193T3 (en) Treatment
GB0802116D0 (en) Treatment
GB0920112D0 (en) Treatment device
GB0822011D0 (en) Treatment
IL217492A0 (en) Treatment method
IL214133A0 (en) Skin treatment
PT2745837T (en) Glomerulonephritis treatment
GB0811992D0 (en) Treatment
GB0900599D0 (en) Treatment
GB201013898D0 (en) Well treatment
GB201013573D0 (en) Treatment
GB0913968D0 (en) Treatment
GB201001521D0 (en) Treatment
PL2263454T3 (en) Treatment composition
GB0916997D0 (en) Combination therapy
GB0820972D0 (en) Treatment
GB0805912D0 (en) Treatment
GB0907973D0 (en) Combination therapy
GB201014097D0 (en) Treatment
GB0901423D0 (en) Treatment
GB0914581D0 (en) Well treatment
GB0916542D0 (en) Well treatment
GB0915045D0 (en) Treatment system
GB0921244D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)